Oxford/AstraZeneca COVID Shot Less Effective Against S.African Variant: Study

British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID19, based on early data from a trial.

from Top World News- News18.com https://ift.tt/3pW430Z
via IFTTT